Are blood and valve cultures predictive for long-term outcome following surgery for infective endocarditis?

被引:28
作者
Renzulli, A [1 ]
Carozza, A [1 ]
Marra, C [1 ]
Romano, G [1 ]
Ismeno, G [1 ]
De Feo, M [1 ]
Della Corte, A [1 ]
Cotrufo, M [1 ]
机构
[1] Univ Naples 2, Inst Cardiac Surg, V Monaldi Hosp, Naples, Italy
关键词
infective endocarditis; blood culture; valve culture;
D O I
10.1016/S1010-7940(00)00342-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To evaluate whether perioperative bacteria identification in blood and/or in valve cultures can predict early and late outcome of surgery for infective endocarditis, a retrospective study was performed, Methods: Between January 1978 and December 1998, 232 patients, 79 (34.1%) female and 153 (65.9%) male with mean age of 44.95 +/- 1.03 years (range 8-79) underwent surgery for infective endocarditis on a native (162 cases) or prosthetic (70 cases) valve. Patients were divided into three groups according to the perioperative x of microbiological tests: Group A: patients with preoperative positive blood cultures (83 cases); Group B: patients with positive valve cultures (35 cases); Group C: patients with negative blood and valve cultures (114 cases). Categorical values were compared by chi(2) analysis, whereas continuous data were compared by ANOVA and Bonferroni correction for post hoc comparisons. Analysis of late survival and complications was performed with Kaplan-Meier and Log Rank test. Late mortality, reoperation, perivalvular leak, recurrence of infection were considered as treatment failure. All data were presented as mean +/- standard error. Results: Hospital mortality was 10.8% (9/83) in Group A, 8.6% (3/35) in Group B, and 14.9% (17/114) in Group C (P = 0.52; not significant (NS)). Ten-year survival was 62.7 +/- 8% in Group A, 43.9 +/- 19% in Group B and 62.7 +/- 7% in Group C (P = 0.38; NS). Ten-year freedom from reoperation was 85.2 +/- 6% in Group A, 37.9 +/- 20% in Group B and 80 +/- 6% in Group C (P = 0.0034). Ten-year freedom from treatment failure was 56.3 +/- 8% in Group A, 31.6 +/- 16% in Group B and 55.3 +/- 7% in Group C (P = 0.46, NS). Conclusions: Positive blood and tissue cultures are not predictive for hospital mortality and late treatment failure in patients with infective endocarditis. Positive valve cultures, a common finding in patients with staphylococcal endocarditis, are predictive for a higher risk of reoperation. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:228 / 233
页数:6
相关论文
共 50 条
  • [21] Role of mitral valve repair in active infective endocarditis: long term results
    Rostagno, Carlo
    Carone, Enrico
    Stefano, Pier Luigi
    JOURNAL OF CARDIOTHORACIC SURGERY, 2017, 12
  • [22] One-year outcome following biological or mechanical valve replacement for infective endocarditis
    Delahaye, F.
    Chu, V. H.
    Altclas, J.
    Barsic, B.
    Delahaye, A.
    Freiberger, T.
    Gordon, D. L.
    Hannan, M. M.
    Hoen, B.
    Kanj, S. S.
    Lejko-Zupanc, T.
    Mestres, C. A.
    Pachirat, O.
    Pappas, P.
    Lamas, C.
    Selton-Suty, C.
    Tan, R.
    Tattevin, P.
    Wang, A.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 178 : 117 - 123
  • [23] Predictive factors and long-term prognosis of transcatheter aortic valve implantation-associated endocarditis
    Tabata, Noriaki
    Al-Kassou, Baravan
    Sugiura, Atsushi
    Shamekhi, Jasmin
    Sedaghat, Alexander
    Treede, Hendrik
    Tsujita, Kenichi
    Werner, Nikos
    Grube, Eberhard
    Nickenig, Georg
    Sinning, Jan-Malte
    CLINICAL RESEARCH IN CARDIOLOGY, 2020, 109 (09) : 1165 - 1176
  • [24] Surgery in drug use-associated infective endocarditis: long-term survival is negatively affected by recurrence
    Rohn, Vilem
    Laca, Branislav
    Horn, Milan
    Vlk, Lukas
    Antonova, Petra
    Mosna, Frantisek
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2020, 30 (04) : 528 - 534
  • [25] Long-term prognosis after surgery for infective endocarditis: Distinction between predictors of early and late survival
    Varela Barca, Laura
    Lopez-Menendez, Jose
    Navas Elorza, Enrique
    Moya Mur, Jose Luis
    Centella Hernendez, Tomasa
    Redondo Palacios, Ana
    Ricardo Fajardo, Edmundo
    Miguelena Hycka, Javier
    Martin Garcia, Miren
    Munoz Perez, Rafael
    Rodriguez-Roda Stuart, Jorge
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2019, 37 (07): : 435 - 440
  • [26] Long-Term Outcome of Infective Endocarditis Involving Cardiac Implantable Electronic Devices: Impact of Comorbidities and Lead Extraction
    Durante-Mangoni, Emanuele
    Ursi, Maria Paola
    Andini, Roberto
    Mattucci, Irene
    Della Ratta, Ester E.
    Iossa, Domenico
    Bertolino, Lorenzo
    De Vivo, Stefano
    Manduca, Sabrina
    Torella, Michele
    De Feo, Marisa
    Zampino, Rosa
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (24)
  • [27] Long-Term Outcomes of Mitral Valve Repair for Active Endocarditis
    Kanemitsu, Hideo
    Nakamura, Ken
    Fukunaga, Naoto
    Koyama, Tadaaki
    CIRCULATION JOURNAL, 2016, 80 (05) : 1148 - 1152
  • [28] Recurrent infective endocarditis versus first-time infective endocarditis after heart valve surgery
    Havers-Borgersen, Eva
    Butt, Jawad H.
    ostergaard, Lauge
    Bundgaard, Henning
    Smerup, Morten
    Bruun, Niels Eske
    Gislason, Gunnar H.
    Torp-Pedersen, Christian
    Kober, Lars
    Fosbol, Emil L.
    CLINICAL RESEARCH IN CARDIOLOGY, 2020, 109 (11) : 1342 - 1351
  • [29] Recurrent infective endocarditis versus first-time infective endocarditis after heart valve surgery
    Eva Havers-Borgersen
    Jawad H. Butt
    Lauge Østergaard
    Henning Bundgaard
    Morten Smerup
    Niels Eske Bruun
    Gunnar H. Gislason
    Christian Torp-Pedersen
    Lars Køber
    Emil L. Fosbøl
    Clinical Research in Cardiology, 2020, 109 : 1342 - 1351
  • [30] Feasibility and outcome of mitral valve repair in patients with infective endocarditis
    Valentina Scheggi
    Iacopo Olivotto
    Stefano Del Pace
    Nicola Zoppetti
    Alterini Brunetto
    Niccolò Marchionni
    Alfredo Cerillo
    Pier Luigi Stefàno
    The Cardiothoracic Surgeon, 28